The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...
(Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of treatment administered every two months for patients with the rare ...
A woman who has received a breakthrough gene-editing treatment on the NHS is hoping 2026 is the year she will be cured of a ...
Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday after the U.S. Food and Drug Administration approved the ...
A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...
With phase 3 trial win, PharmaEssentia plots label expansion for rare blood cancer treatment Besremi
PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood disorder after reviewing encouraging results from a phase 3 study. In the ...
A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of ...
Abu Dhabi successfully completes its first gene therapy for genetic blood disorders, revolutionizing treatment approaches for ...
Blood disorders affect millions of Americans, yet many don’t realize these conditions can sometimes transform into something far more serious. With approximately 1.3 million people currently living ...
Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback